Pfizer Inc
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie announced plans to buy cancer drug developer ImmunoGen for $10.1 billion. Shares of ImmunoGen jumped more than 80% on Thursday, putting it on track for its highest […]
Read More
Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them
A sign advertises Covid vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, on Aug. 14, 2023. Brian Snyder | Reuters Three years into the Covid-19 pandemic, few Americans are rolling up their sleeves to get a Covid vaccine. Only 15.7% of U.S. adults had received the newest Covid shots from Pfizer, Moderna and Novavax […]
Read More
Tim Prepare dinner, Elon Musk, Steve Schwarzman noticed at Xi Jinping meal with U.S. CEOs
Major company leaders in the U.S. fulfill Chinese President Xi Jinping in San Francisco, California on Nov. 15, 2023. Eamon Javers, CNBC Correspondent Apple CEO Tim Prepare dinner, Tesla main Elon Musk and Blackstone’s Steve Schwarzman ended up amongst the company Wednesday night at a gala reception and meal in San Francisco for visiting Chinese […]
Read More
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
CFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding weight loss drug market. Analysts say upcoming data on Pfizer’s experimental obesity pill, danuglipron, will be crucial in determining how competitive the company can be against the space’s dominant players Eli Lilly and Novo Nordisk. Those […]
Read More
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023. George Frey | Reuters Eli Lilly on Thursday said supply of its blockbuster diabetes drug Mounjaro has improved in the U.S. after months of widespread […]
Read More
Moderna stock falls 10% as hefty Covid vaccine write-downs drive big loss
Moderna on Thursday posted a steep loss for the third quarter as the drugmaker recorded a large write-down due to unused doses of its Covid vaccine, its only marketable product. Moderna’s total revenue for the period topped Wall Street’s expectations, even amid plummeting demand for its shot. Its outlook for next year, however, came in […]
Read More
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected loss for the third quarter as the drugmaker recorded charges largely related to struggles for its Covid antiviral treatment Paxlovid and Covid vaccine. Pfizer said that it recorded a $5.6 billion charge for inventory write-offs in the third quarter due […]
Read More
Inventory futures are small altered following important averages rebound to start the 7 days: Live updates
A trader is effective on the floor of the New York Stock Trade on Oct. 20, 2023. Michael Nagle | Bloomberg | Getty Photos U.S. stock futures were being flat Monday night time right after the key averages climbed in a reduction rally. S&P 500 futures and Nasdaq 100 futures just about every inched lower […]
Read More
These stocks have earnings momentum heading into their reports this 7 days
A different chunk of providers are established to report this 7 days, and analysts think earnings are on their aspect. About 50% of S & P 500 corporations have described earnings for the 3rd quarter. Of those businesses, approximately 77% have exceeded expectations, FactSet info exhibits. About 30% of S & P 500 businesses are […]
Read More
CNBC Day-to-day Open up: Are points about to get a lot more difficult?
Up from No. 13 in 2022, Minneapolis, Minnesota ranked as the No. 2 most neighborly city in The usa. S. Greg Panosian | E+ | Getty Photos This report is from today’s CNBC Each day Open, our new, international marketplaces e-newsletter. CNBC Every day Open delivers investors up to velocity on every little thing they […]
Read More